A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities ...
* Off-label use of GLP-1 drugs reflects cultural pressures that link thinness with moral value * Individuals using these medications without clinical need face unclear risks, both physiological //and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results